Search All News
In people with dementia, delirium during COVID-19 is more common but deaths from COVID-19 are not disproportionately higher, finds a new study.
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
A new Columbia study suggests that malfunctioning endosomes—a central trafficking station inside neurons—are commonly involved in the appearance of Alzheimer’s disease.
- January 24, 2018
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.
- January 16, 2018
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
- November 22, 2017
New video that reveals how immune cells breach the blood-brain barrier is giving scientists new ideas about treating multiple sclerosis.
- November 17, 2017
Researchers at Columbia University found that dementia is on the decline in seniors from northern Manhattan, following national trends.
- November 13, 2017
A new study suggests a smell test can identify people with mild cognitive impairment–often a precursor to Alzheimer’s–who may benefit from cholinesterase inhibitors.
- November 8, 2017
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.
- October 3, 2017
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
- September 18, 2017
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.